Graf Akcie HAE (Haemonetics Corp.). Diskuze k akciím HAE. Aktuální informace HAE.

Základní informace o společnosti Haemonetics Corp. (Akcie HAE)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 3.56B
Hodnota podniku (EV) 4.21B
Tržby 903.414M
EBITDA 82.216M
Zisk 64.488M
Růst v tržbách Q/Q 16.85 %
Růst v tržbách Y/Y -4.46 %
P/E (Cena vůči ziskům) 55.05
Forward P/E 0.87
EV/Sales 4.66
EV/EBITDA 51.16
EV/EBIT 52.96
PEG 2.20
Price/Sales 3.94
P/FCF 65.91
Price/Book 4.87
Účetní hodnota na akcii 14.36
Hotovost na akcii 3.78
FCF vůči ceně 1.52 %
Počet zaměstnanců 2,708
Tržba na zaměstnance 333.609k
Profit margin 9.13 %
Operating margin 8.79 %
Gross margin 45.70 %
EBIT margin 8.79 %
EBITDA margin 9.10 %
EPS - Zisk na akcii 1.27
EPS - Kvartální růst 8.70 %
EPS - Očekávaný růst příští rok -1.61 %
Return on assets 4.06 %
Return on equity 9.23 %
ROIC 5.81 %
ROCE 5.07 %
Dluhy/Equity 1.49
Čistý dluh/EBITDA 17.42
Current ratio 3.00
Quick Ratio 1.57
Volatilita 2.85
Beta 0.86
RSI 56.21
Cílová cena analytiků 118
Známka akcie (dle analytiků) 1.14
Insider ownership 0.60 %
Institutional ownership 98.91 %
Počet akcií 51.03M
Procento shortovaných akcií 4.10 %
Short ratio 4.36 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1991
Země United States

Finanční výsledky akcie HAE

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$988.479$967.579$903.923$886.116$908.832$910.373
Cost Of Goods Sold$503.966$550.043$492.015$507.622$502.918$475.955
Gross Profit$484.513$417.536$411.908$378.494$405.914$434.418
Research And Development Expenses$30.883$35.714$39.228$37.556$44.965$54.187
SG&A Expenses$299.68$298.277$316.523$301.726$317.223$337.168
Other Operating Income Or Expenses$-50.599--$-58.593$-87.668$-2.523
Operating Expenses$885.128$884.034$847.766$905.497$952.774$869.833
Operating Income$103.351$83.545$56.157$-19.381$-43.942$40.54
Total Non-Operating Income/Expense$-16.199$-9.912$3.475$-8.095$-9.474$-9.375
Pre-Tax Income$87.152$73.633$59.632$-27.476$-53.416$31.165
Income Taxes$10.626$18.614$14.06$-1.208$2.163$14.268
Income After Taxes$76.526$55.019$45.572$-26.268$-55.579$16.897
Other Income------
Income From Continuous Operations$76.526$55.019$45.572$-26.268$-55.579$16.897
Income From Discontinued Operations------
Net Income$76.526$55.019$45.572$-26.268$-55.579$16.897
EBITDA$213.64$192.963$145.404$70.352$45.969$126.593
EBIT$103.351$83.545$56.157$-19.381$-43.942$40.54
Basic Shares Outstanding515253525152
Shares Outstanding525354525152
Basic EPS$1.51$1.07$0.86$-0.51$-1.09$0.33
EPS - Earnings Per Share$1.48$1.04$0.85$-0.51$-1.09$0.32
# 2020 2019 2018 2017 2016 2015
Current Ratio2.19652.44371.35482.41522.63052.9556
Long-term Debt / Capital0.34230.32560.07320.25540.33560.3297
Debt/Equity Ratio0.65150.52420.33720.42540.56540.518
Gross Margin49.01643.152745.568942.713844.663347.7187
Operating Margin10.45568.63446.2126-2.1872-4.8354.4531
EBIT Margin10.45568.63446.2126-2.1872-4.8354.4531
EBITDA Margin21.61319.942916.08597.93945.05813.9056
Pre-Tax Profit Margin8.81687.616.597-3.1007-5.87743.4233
Net Profit Margin7.74185.68635.0416-2.9644-6.11541.8561
Asset Turnover0.78010.7590.73050.71540.6890.6129
Inventory Turnover Ratio1.86462.83043.05982.86912.6892.2549
Receiveable Turnover5.98335.22945.97735.80365.78536.2428
Days Sales In Receivables61.003469.797861.064462.891663.090858.4671
ROE - Return On Equity13.03448.2386.0567-3.5516-7.70262.0453
Return On Tangible Equity31.446816.70511.854-7.4789-22.2976.8347
ROA - Return On Assets6.03944.3163.6831-2.1206-4.21331.1375
ROI - Return On Investment8.57325.55575.6133-2.6447-5.11731.371
Book Value Per Share11.666813.090314.37514.153914.167215.9881
Operating Cash Flow Per Share0.0449-1.111.01830.7066-0.0479-0.2222
Free Cash Flow Per Share1.6215-1.95741.09471.28260.2909-1.1631